Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
Clinical trial NCT00003991 · COMPLETED
Trial details
- NCT number
- NCT00003991
- Sponsor
- Maxim Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-07-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.